Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LUNELLE | Pharmacia & Upjohn | N-020874 DISCN | 2000-10-05 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
premphase | ANDA | 2012-11-26 |
premphase prempro | New Drug Application | 2023-11-29 |
prempro | New Drug Application | 2020-05-28 |
Code | Description |
---|---|
J1050 | Injection, medroxyprogesterone acetate, 1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Contraception | D003267 | — | — | 14 | 4 | 1 | 12 | 18 | 46 |
Endometrial neoplasms | D016889 | EFO_0004230 | — | — | 12 | 4 | 1 | 2 | 17 |
Hiv infections | D015658 | EFO_0000764 | B20 | 2 | 3 | — | 1 | 5 | 11 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 2 | 4 | 2 | 2 | 9 |
Postmenopause | D017698 | — | — | 3 | 1 | 3 | 1 | 1 | 9 |
Infertility | D007246 | HP_0000789 | — | — | — | 2 | 4 | 2 | 8 |
Hiv | D006678 | — | O98.7 | — | 1 | — | 3 | 4 | 8 |
Endometrial hyperplasia | D004714 | — | N85.0 | 1 | 4 | 2 | 2 | — | 7 |
Osteoporosis | D010024 | HP_0000939 | M81.0 | — | — | 3 | 3 | — | 6 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 1 | 2 | 1 | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Menopause | D008593 | EFO_0003922 | N95 | — | 3 | 2 | — | — | 5 |
Uterine hemorrhage | D014592 | — | — | 1 | 1 | 2 | — | 2 | 5 |
Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | 3 | — | 2 | 5 |
Coronary disease | D003327 | — | — | — | 1 | 5 | — | — | 5 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 1 | 5 | — | — | 5 |
Healthy volunteers/patients | — | — | — | 3 | 1 | 1 | — | — | 4 |
Anorexia nervosa | D000856 | EFO_0004215 | F50.0 | 2 | 1 | 1 | — | — | 3 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 3 | — | — | 3 |
Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | — | 1 | 1 | — | — | 2 |
Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Endometrioid carcinoma | D018269 | — | — | — | 2 | — | — | — | 2 |
Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 1 | — | — | — | 1 |
Prehypertension | D058246 | — | — | — | 1 | — | — | — | 1 |
Persistent fetal circulation syndrome | D010547 | EFO_1001103 | P29.3 | — | 1 | — | — | — | 1 |
Epilepsy | D004827 | EFO_0000474 | G40.9 | — | 1 | — | — | — | 1 |
Myelodysplastic syndromes | D009190 | — | D46 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Contraception behavior | D003268 | — | — | 1 | — | — | — | 5 | 6 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | 2 | — | — | — | 1 | 3 |
Postcoital contraception | D044363 | — | — | 1 | — | — | — | 1 | 2 |
Kidney transplantation | D016030 | — | — | 1 | — | — | — | — | 1 |
Immunosuppression therapy | D007165 | — | — | 1 | — | — | — | — | 1 |
Pregnancy rate | D018873 | — | — | 1 | — | — | — | — | 1 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | — | 1 |
Estrogen replacement therapy | D015914 | — | — | 1 | — | — | — | — | 1 |
Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fertility | D005298 | — | — | — | — | — | — | 2 | 2 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
Premenstrual dysphoric disorder | D065446 | — | F32.81 | — | — | — | — | 1 | 1 |
Psychotic disorders | D011618 | — | F20.81 | — | — | — | — | 1 | 1 |
Panic disorder | D016584 | EFO_0004262 | F41.0 | — | — | — | — | 1 | 1 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | — | — | — | 1 | 1 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | — | — | — | — | 1 | 1 |
Obsessive-compulsive disorder | D009771 | EFO_0004242 | F42 | — | — | — | — | 1 | 1 |
Social phobia | D000072861 | EFO_1001917 | F40.1 | — | — | — | — | 1 | 1 |
Dysthymic disorder | D019263 | EFO_0008623 | F34.1 | — | — | — | — | 1 | 1 |
Drug common name | Medroxyprogesterone acetate |
INN | medroxyprogesterone |
Description | Medroxyprogesterone acetate is an acetate ester resulting from the formal condensation of the 17alpha-hydroxy group of medroxyprogesterone with the carboxy group of acetic acid. A widely used progestin in menopausal hormone therapy and in progestogen-only birth control. It has a role as a progestin, an androgen, a female contraceptive drug, a synthetic oral contraceptive, an adjuvant, an inhibitor, an antioxidant and an antineoplastic agent. It is a steroid ester, an acetate ester, a 20-oxo steroid, a 3-oxo-Delta(4) steroid and a corticosteroid. It is functionally related to a medroxyprogesterone. |
Classification | Small molecule |
Drug class | progestins; steroids (androgens, anabolics); antiandrogens |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C |
PDB | — |
CAS-ID | 71-58-9 |
RxCUI | — |
ChEMBL ID | CHEMBL717 |
ChEBI ID | 6716 |
PubChem CID | 6279 |
DrugBank | DB00603 |
UNII ID | HSU1C9YRES (ChemIDplus, GSRS) |